You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TBL1XR1-RET

Showing 1 - 25 of 1,475
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

Active, not recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +39 more
  • pralsetinib (BLU-667)
  • Phoenix, Arizona
  • +65 more
Nov 10, 2022

RET-altered Solid Tumors Trial in Shanghai (APS03118)

Recruiting
  • RET-altered Solid Tumors
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Dec 8, 2022

Advanced Hepatocellular Carcinoma Trial (Tegavivint, Pembrolizumab)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • (no location specified)
Mar 21, 2023

Chemotherapy or Chemotherapy Plus PD-1 Antibody in RET Fusion

Recruiting
  • Non-small Cell Lung Cancer
    • Changsha, Hunan, China
      Yongchang Zhang
    Mar 1, 2022

    Lung Cancer, Non Small Cell Lung Cancer Trial in Aurora (Amivantamab 1050mg, Amivantamab 1400mg, Amivantamab (to be determined))

    Not yet recruiting
    • Lung Cancer
    • Non Small Cell Lung Cancer
    • Amivantamab 1050mg
    • +2 more
    • Aurora, Colorado
    • +2 more
    Apr 25, 2023

    NSCLC, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (LOXO-292)

    Recruiting
    • Non-Small Cell Lung Cancer
    • +3 more
    • Scottsdale, Arizona
    • +84 more
    Oct 10, 2022

    Type 2 Diabetes Trial in Daejeon (CT-L01, Alogliptin Benzoate 25 mg, Metformin HCl XR 1,000 mg)

    Completed
    • Healthy
    • Daejeon, Korea, Republic of
      Chungnam National University Hospital
    Jan 10, 2023

    ALK-positive NSCLC (NSCLC), RET-positive NSCLC (NSCLC), RET-positive Thyroid Cancer Trial in Irvine, Boston (Alectinib)

    Terminated
    Has Results
    • ALK-positive Non-small Cell Lung Cancer (NSCLC)
    • +2 more
    • Irvine, California
    • +3 more
    Aug 30, 2021

    Diabetes type1, Diabetes type2 Trial in Salford (Device: Actiste 1.0 and the Companion app with TBL Backend)

    Recruiting
    • Diabetes type1
    • Diabetes type2
    • Device: Actiste 1.0 and the Companion app with TBL Backend
    • Salford, Greater Manchester, United Kingdom
      Salford Royal Hospital Northern Care Alliance NHS Foundation Tru
    Sep 30, 2022

    Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET Gene Mutation Trial in Korea, Republic of, United States (TPX-0046)

    Recruiting
    • Non Small Cell Lung Cancer
    • +4 more
    • Irvine, California
    • +15 more
    Mar 9, 2022

    Healthy Trial in Adelaide (TR-01-XRR (1), TR-01-XRR (2), TR-01-XRR (3))

    Not yet recruiting
    • Healthy
    • TR-01-XRR (1)
    • +6 more
    • Adelaide, South Australia, Australia
      CMAX Clinical Research
    Feb 3, 2023

    Advanced Nonhaematologic Malignancies Trial in Worldwide (BOS172738)

    Active, not recruiting
    • Advanced Nonhaematologic Malignancies
    • Philadelphia, Pennsylvania
    • +20 more
    Sep 23, 2022

    Advanced Solid Tumor Trial (HEC169096)

    Not yet recruiting
    • Advanced Solid Tumor
    • (no location specified)
    Jul 6, 2022

    Adult Attention-deficit Hyperactivity Disorder (ADHD) Trial in Melbourne (CTN SR1, CTN XR1, CTN XR2)

    Terminated
    • Adult Attention-deficit Hyperactivity Disorder (ADHD)
    • CTN SR1
    • +3 more
    • Melbourne, Australia
      (unnamed)
    Feb 15, 2022

    Ovarian Tumors, BRCA1 Protein, BRCA2 Protein Trial in Worldwide (KU-0059436 (AZD2281)(PARP inhibitor))

    Active, not recruiting
    • Ovarian Neoplasms
    • +2 more
    • KU-0059436 (AZD2281)(PARP inhibitor)
    • Brussels, Belgium
    • +4 more
    Dec 19, 2022

    Overweight, Obesity Trial in São Paulo (ADF1 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 75mg, ADF2

    Not yet recruiting
    • Overweight
    • Obesity
    • ADF1 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 75mg
    • +3 more
    • São Paulo, SP, Brazil
      HC-FMUSP
    Jul 28, 2022

    Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Everolimus, Laboratory

    Recruiting
    • Advanced Malignant Neoplasm
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 9, 2022

    Plasminogen Activator Inhibitor-1 Deficiency, Cardiac Fibrosis Trial (Metformin Extended Release Oral Tablet)

    Not yet recruiting
    • Plasminogen Activator Inhibitor-1 Deficiency
    • Cardiac Fibrosis
    • Metformin Extended Release Oral Tablet
    • (no location specified)
    Aug 1, 2022

    SARS-CoV-2 Infection / COVID-19 in Type 1 Diabetes

    Completed
    • SARS-CoV2 Infection
    • Diabetes Mellitus, Type 1
    • venous blood sample
    • Llantrisant, Rhondda Cynon Taf, United Kingdom
      Cwm Taf Morgannwg University Health board
    May 30, 2022

    Type II Diabetes Trial (T1: FDC 5/500 mg; R1+R: SHR3824 5 mg + Metformin 500 mg XR, T2: FDC 5/1000 mg; R2+R: SHR3824 5 mg + two

    Not yet recruiting
    • Type II Diabetes
    • T1: FDC 5/500 mg; R1+R: SHR3824 5 mg + Metformin 500 mg XR
    • T2: FDC 5/1000 mg; R2+R: SHR3824 5 mg + two Metformin 500 mg XR
    • (no location specified)
    Nov 3, 2021

    Healthy Volunteers Trial in Overland Park (Emraclidine, Itraconazole, Carbamazepine)

    Recruiting
    • Healthy Volunteers
    • Overland Park, Kansas
      Overland Park, Kansas
    Jul 20, 2023

    Alpha-1-antitrypsin Deficiency, Liver Cirrhosis Trial in Saint Louis, Pittsburgh (Drug-Carbamazepine (Tegretol XR),

    Terminated
    Has Results
    • Alpha-1-antitrypsin Deficiency
    • Liver Cirrhosis
    • Drug-Carbamazepine (Tegretol XR)
    • Carbamazepine (Tegretol XR) Placebo
    • Saint Louis, Missouri
    • +2 more
    Oct 7, 2021

    Carcinoma of Unknown Primary: A Comparison Across Tissue and

    Recruiting
    • Cancer of Unknown Primary Site
      • Bath, United Kingdom
      • +6 more
      Oct 18, 2022

      Migraine Disorders Trial in United States (Qudexy XR, Placebo)

      Recruiting
      • Migraine Disorders
      • Qudexy XR
      • Placebo
      • Birmingham, Alabama
      • +10 more
      Apr 26, 2022

      Healthy Trial in Miami (LDX + Venlafaxine XR, Venlafaxine XR + LDX)

      Completed
      Has Results
      • Healthy
      • LDX + Venlafaxine XR
      • Venlafaxine XR + LDX
      • Miami, Florida
        Clinical Pharmacology of Miami
      Jun 8, 2021